AZD9496
AZD9496 : ESR1 antagonist
Structure
In Cells
In Model Organisms
SERP ratings and comments
SERP Ratings
(last updated: 7 Jul 2021 )
SERP Ratings
SERP Comments:
The compound AZD9496 was the lead candidate for orally bioavailable selective estrogen receptor downregulator (SERD) with equivalent potency and preclinical pharmacology to the intramuscular SERD fulvestrant. Most recently, the compound was put on clinical hold and replaced by AZD9833, a backup compound with a superior profile for safety and efficacy. In addition, there is excellent cellular data using two cell lines (MCF-7 and CAMA-1) for AZD9833. AZD9496 should be replaced by AZD9833 as the chemical probe; it still possesses very good properties can be used as a secondary probe.
(last updated: 27 Jul 2021 )
SERP Ratings
(last updated: 6 Sept 2021 )